EP2760853A4 - Neuartige salze aus alogliptin - Google Patents

Neuartige salze aus alogliptin

Info

Publication number: EP2760853A4
Authority: EP; European Patent Office
Prior art keywords: alogliptin; novel salts; salts; novel
Prior art date: 2011-09-26
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP12836162.3A

Other languages

English (en)

French (fr)

Other versions

EP2760853A1 (de

Inventor

Reddy Bandi Parthasaradhi

Reddy Kura Rathnakar

Reddy Dasari Muralidhara

Maradolla Mohanbabu

Krishna Bandi Vamsi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hetero Research Foundation

Original Assignee

Hetero Research Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-09-26

Filing date

2012-09-12

Publication date

2015-10-28

2012-09-12 Application filed by Hetero Research Foundation filed Critical Hetero Research Foundation

2014-08-06 Publication of EP2760853A1 publication Critical patent/EP2760853A1/de

2015-10-28 Publication of EP2760853A4 publication Critical patent/EP2760853A4/de

Status Withdrawn legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP12836162.3A 2011-09-26 2012-09-12 Neuartige salze aus alogliptin Withdrawn EP2760853A4 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN3317CH2011		2011-09-26
PCT/IN2012/000611 WO2013046229A1 (en)	2011-09-26	2012-09-12	Novel salts of alogliptin

Publications (2)

Publication Number	Publication Date
EP2760853A1 EP2760853A1 (de)	2014-08-06
EP2760853A4 true EP2760853A4 (de)	2015-10-28

Family

ID=47994371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP12836162.3A Withdrawn EP2760853A4 (de)	2011-09-26	2012-09-12	Neuartige salze aus alogliptin

Country Status (2)

Country	Link
EP (1)	EP2760853A4 (de)
WO (1)	WO2013046229A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9776985B2 (en)	2013-05-24	2017-10-03	Glenmark Pharmaceuticals Limited	Process for preparation of alogliptin
CN104725350A (zh) *	2013-12-23	2015-06-24	湖北华世通生物医药科技有限公司	阿格列汀盐酸盐的多晶b型晶体、其制备方法及生产用途
CN103923063B (zh) *	2014-04-11	2016-05-11	浙江永宁药业股份有限公司	一种苯甲酸阿格列汀的晶型及其制备方法
WO2016178246A1 (en)	2015-05-04	2016-11-10	Indoco Remedies Limited	Process for the preparation of alogliptin
WO2017107945A1 (zh) *	2015-12-24	2017-06-29	山东轩竹医药科技有限公司	二肽基肽酶-iv抑制剂的苯甲酸盐的晶型
CN109219607B (zh) *	2016-06-08	2021-03-30	吉林惠升生物制药有限公司	二肽基肽酶-iv抑制剂的丁二酸盐的晶型
CN105929084B (zh) *	2016-07-18	2018-11-23	江苏德源药业股份有限公司	高效液相色谱拆分苯甲酸阿格列汀及其对映异构体的方法
CN106749177A (zh) *	2016-12-30	2017-05-31	湖南千金湘江药业股份有限公司	一种苯甲酸阿格列汀的精制方法
CN113880900B (zh) *	2020-10-30	2023-07-07	杭州拉林智能科技有限公司	黄酮苷-有机胺类dpp-4抑制剂复盐化合物及其制备方法和应用
CN113698384B (zh) *	2021-10-26	2022-01-18	上海维京生物医药科技有限公司	阿格列汀没食子酸盐及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005095381A1 (en) *	2004-03-15	2005-10-13	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
WO2007033266A2 (en) *	2005-09-14	2007-03-22	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors for treating diabetis
WO2007035629A2 (en) *	2005-09-16	2007-03-29	Takeda Pharmaceutical Company Limited	Process for the preparation of pyrimidinedione derivatives
WO2010109468A1 (en) *	2009-03-26	2010-09-30	Mapi Pharma Hk Limited	Process for the preparation of alogliptin
WO2011141903A1 (en) *	2010-05-12	2011-11-17	Mapi Pharma Holdings (Cyprus) Limited	Polymorphs of alogliptin benzoate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1661878A1 (de) *	2004-11-26	2006-05-31	Dipharma S.p.A.	Polymorphe Formen von Adapalene
TW200745079A (en) *	2005-09-16	2007-12-16	Takeda Pharmaceuticals Co	Polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
EP2271320A4 (de) *	2008-04-02	2011-05-18	Reddys Lab Ltd Dr	Pharmazeutische raloxifenformulierungen

2012
- 2012-09-12 WO PCT/IN2012/000611 patent/WO2013046229A1/en not_active Ceased
- 2012-09-12 EP EP12836162.3A patent/EP2760853A4/de not_active Withdrawn

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005095381A1 (en) *	2004-03-15	2005-10-13	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors
WO2007033266A2 (en) *	2005-09-14	2007-03-22	Takeda Pharmaceutical Company Limited	Dipeptidyl peptidase inhibitors for treating diabetis
WO2007035629A2 (en) *	2005-09-16	2007-03-29	Takeda Pharmaceutical Company Limited	Process for the preparation of pyrimidinedione derivatives
WO2010109468A1 (en) *	2009-03-26	2010-09-30	Mapi Pharma Hk Limited	Process for the preparation of alogliptin
WO2011141903A1 (en) *	2010-05-12	2011-11-17	Mapi Pharma Holdings (Cyprus) Limited	Polymorphs of alogliptin benzoate

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2013046229A1 *

Also Published As

Publication number	Publication date
WO2013046229A1 (en)	2013-04-04
EP2760853A1 (de)	2014-08-06

Publication	Publication Date	Title
HUE047354T2 (hu)	2020-04-28	Ivacaftor deuterizált származékai
PT2709986T (pt)	2017-06-26	Derivados deuterados de ivacaftor
EP2712362A4 (de)	2014-12-24	Herstellung von lacto-n-tetraose
IL229830B (en)	2018-12-31	Novel compinds as modulatord of gpr-119
EP2717855A4 (de)	2014-11-12	Behandlungsverfahren
IL232599A (en)	2017-03-30	Hydrobromide salt of peridofidine
EP2739221A4 (de)	2015-03-04	Chirurgischer anker
GB201304499D0 (en)	2013-04-24	Carcainium Salts
EP2760853A4 (de)	2015-10-28	Neuartige salze aus alogliptin
IL230976A0 (en)	2014-03-31	Crystalline forms of cvezitaxel
EP2776393A4 (de)	2015-05-27	Nampt-inhibitoren
PT2739276T (pt)	2019-05-27	Composição antisséptica
GB201119999D0 (en)	2012-01-04	Vaccine
EP2601178A4 (de)	2013-11-13	Salze von lapatinib
EP2680843A4 (de)	2015-05-06	Derivate von pyrazolsubstituierten amino-heteroaryl-verbindungen
GB201118334D0 (en)	2011-12-07	Novel dosage form
EP2684869A4 (de)	2014-08-20	Herstellung von 3-mercaptopropionaten
IL230977A (en)	2016-08-31	A crystalline form of relapaldib
EP2782902A4 (de)	2015-08-26	Derivate aus phenoxyisobuttersäure
GB201120000D0 (en)	2012-01-04	Vaccine
PL395425A1 (pl)	2013-01-07	Sposób wytwarzania chlorowodorku 2-amino-N-tert-butylo-2- cyjanoacetamidu
GB201102913D0 (en)	2011-04-06	Novel therapeutic
GB201201857D0 (en)	2012-03-21	Pseudonymisation/de-pseudonymisation of data
GB201106819D0 (en)	2011-06-01	Novel salts
GB201104632D0 (en)	2011-05-04	Use of medicament

Legal Events

Date	Code	Title	Description
2014-07-04	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2014-08-06	17P	Request for examination filed	Effective date: 20140402
2014-08-06	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
2014-12-31	DAX	Request for extension of the european patent (deleted)
2015-04-15	RIC1	Information provided on ipc code assigned before grant	Ipc: C07D 401/04 20060101AFI20150310BHEP
2015-10-28	RA4	Supplementary search report drawn up and despatched (corrected)	Effective date: 20150924
2015-10-28	RIC1	Information provided on ipc code assigned before grant	Ipc: C07D 401/04 20060101AFI20150918BHEP
2016-10-19	17Q	First examination report despatched	Effective date: 20160916
2018-01-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2018-02-28	18D	Application deemed to be withdrawn	Effective date: 20170923